New treatment option for Neurogenic Bowel Dysfunction
Official title Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
ClinicalTrials.gov ID: NCT07213986
What this study is testing
- What it's testing
- The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Individuals with chronic spinal cord injury (SCI) of more than one year.
- Stable neurological level and function of SCI for at least six months.
- Consistent bowel program without changes for at least 3 months.
- At least one scheduled bowel movement (BM) every three days.
- Use of digital stimulation, suppositories, enemas, or mini enemas, as part of the scheduled bowel program.
You likely can't join if
- Bowel incontinence occurring more than once per week.
- Non-English-speaking individuals.
- History of bowel obstruction, ileus, diverticulitis, or bowel surgery for a disease (appendix removal is ok).
- Persistent autonomic dysreflexia (AD) triggered by bowel movements.
- Recent changes to spasticity medications within the past month.
- History of significant gastrointestinal disorders
See the full eligibility criteria
- Individuals with chronic spinal cord injury (SCI) of more than one year.
- Stable neurological level and function of SCI for at least six months.
- Consistent bowel program without changes for at least 3 months.
- At least one scheduled bowel movement (BM) every three days.
- Use of digital stimulation, suppositories, enemas, or mini enemas, as part of the scheduled bowel program.
- Use of oral medications as part of the bowel program.
- Bowel incontinence occurring more than once per week.
- Non-English-speaking individuals.
- History of bowel obstruction, ileus, diverticulitis, or bowel surgery for a disease (appendix removal is ok).
- Persistent autonomic dysreflexia (AD) triggered by bowel movements.
- Recent changes to spasticity medications within the past month.
- History of significant gastrointestinal disorders
- History of Zenker's diverticulum
- Dysphagia
- Esophageal stricture
- Eosinophilic esophagitis or achalasia
- Pregnancy.
- Presence of implanted devices that could be affected by proximity to a direct current magnetic field.
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.